Time to biochemical and radiographic progression in patients treated with adenovirus-PSA vaccine for non-metastatic/early metastatic castrate-resistant prostate cancer: Phase 2 trial results

Abstract

Peer reviewed

Daniel A. Vaena, Kenneth Gerard Nepple, James A. Brown, Karen Griffith, Pamela Zehr and David Lubaroff

Journal of clinical oncology, Vol.33(15_suppl), pp.e16132-e16132

05/20/2015

DOI: 10.1200/jco.2015.33.15_suppl.e16132

View Online

Title: Subtitle: Time to biochemical and radiographic progression in patients treated with adenovirus-PSA vaccine for non-metastatic/early metastatic castrate-resistant prostate cancer: Phase 2 trial results
Creators: Daniel A. Vaena - University of Iowa
Kenneth Gerard Nepple - University of Iowa
James A. Brown - University of Iowa
Karen Griffith - Iowa City VA Medical Center
Pamela Zehr - University of Iowa
David Lubaroff - University of Iowa
Resource Type: Abstract
Publication Details: Journal of clinical oncology, Vol.33(15_suppl), pp.e16132-e16132
DOI: 10.1200/jco.2015.33.15_suppl.e16132
ISSN: 0732-183X
eISSN: 1527-7755
Language: English
Date published: 05/20/2015
Academic Unit: Roy J. Carver Department of Biomedical Engineering; Internal Medicine; Urology
Record Identifier: 9984321551502771

16 Record Views